Catalyst Wire Dossier Catalyst Wire Dossier

Meningococcal A,C,W-135,Y conjugate vaccine

Meningococcal conjugate vaccine (serogroups A, C, W-135, Y) · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Meningococcal A,C,W-135,Y conjugate vaccine, covering 2016-09-07 to 2016-09-21. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate 4 Different Formulations of Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs [Phase 2]

See pricing